Homestead Advisers Corp Abbott Laboratories Transaction History

Homestead Advisers Corp

$3.96 Billion
Q4 2024

A detailed history of Homestead Advisers Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Homestead Advisers Corp holds 906,946 shares of ABT stock, worth $125 Million. This represents 2.59% of its overall portfolio holdings.

Number of Shares

906,946

Previous 924,846 1.94%

Holding current value

$125 Million

Previous $105 Million 2.71%

% of portfolio

2.59%

Previous 2.56%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $2 Million - $2.14 Million	-17,900 Reduced 1.94%	906,946 $103 Million
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $7.35 Million - $8.67 Million	-73,400 Reduced 7.35%	924,846 $105 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $1.63 Million - $1.82 Million	-16,200 Reduced 1.6%	998,246 $104 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $87,616 - $96,768	-800 Reduced 0.08%	1,014,446 $115 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $7.75 Million - $9.48 Million	-85,900 Reduced 7.8%	1,015,246 $112 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $14.4 Million - $17.3 Million	-151,089 Reduced 12.07%	1,101,146 $107 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $17.4 Million - $19.4 Million	172,789 Added 16.01%	1,252,235 $137 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $5.31 Million - $6.25 Million	-54,800 Reduced 4.83%	1,079,446 $109 Million
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $3.23 Million - $3.79 Million	-34,000 Reduced 2.91%	1,134,246 $125 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $251,576 - $291,278	-2,600 Reduced 0.22%	1,168,246 $113 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $2.19 Million - $2.67 Million	-19,200 Reduced 1.61%	1,170,846 $139 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $982,005 - $1.2 Million	-8,500 Reduced 0.71%	1,190,046 $167 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $4.55 Million - $5.03 Million	-39,000 Reduced 3.15%	1,198,546 $142 Million
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $4.02 Million - $4.73 Million	-38,000 Reduced 2.98%	1,237,546 $143 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $6.76 Million - $7.96 Million	-62,100 Reduced 4.64%	1,275,546 $153 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $3.55 Million - $3.87 Million	-33,800 Reduced 2.46%	1,337,646 $146 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $12.7 Million - $15.4 Million	-138,200 Reduced 9.15%	1,371,446 $149 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $76,570 - $98,000	1,000 Added 0.07%	1,509,646 $138 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $2.68 Million - $3.92 Million	-42,719 Reduced 2.75%	1,508,646 $119 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $1.2 Million - $1.33 Million	-15,251 Reduced 0.97%	1,551,365 $135 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $4.29 Million - $4.65 Million	-52,384 Reduced 3.24%	1,566,616 $131 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $327,800 - $371,350	5,000 Added 0.31%	1,619,000 $117 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $77.6 Million - $86.6 Million	1,614,000	1,614,000 $86.1 Million

Others Institutions Holding ABT

# of Institutions

3,370

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $241B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.

Account

Homestead Advisers Corp Abbott Laboratories Transaction History